Interstitial brachytherapy for malignant brain tumors

Seminars in Surgical Oncology

Volumn 14, Issue 1, 1998, Pages 79-87

  McDermott, Michael W ^a   Sneed, Penny K ^a   Gutin, Philip H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brachytherapy; Brain neoplasms; Costbenefit analysis; Glioma; Induced hyperthermia; Neoplasm metastasis; Radiation dosage; Radioisotopes; Radiotherapy; Survival rate

Indexed keywords

COBALT 60; GOLD 198; IODINE 125; IRIDIUM 192; PALLADIUM;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; COST BENEFIT ANALYSIS; GLIOBLASTOMA; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0030831602     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2388(199801/02)14:1<79::aid-ssu10>3.0.co;2-4     Document Type: Article

References (59)

1. Halligan JB, Stelzer KJ, Rostomily RC, et al: Opération and permanent low activity 1251 brachytherapy for recurrent highgrade astrocytomas [Review]. Int J Radiât Oncol Biol Phys 1996; 35:541-547.
2. Sneed PK, Lamborn KR, Larson DA, et al. : Démonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiât Oncol Biol Phys 1996; 35:37-44.
3. McDermott MW, Gutin PH, Larson DA, Sneed PK: Interstitial brachytherapy [Review]. Neurosurg Clin NA 1990; 1:801-824.
4. Weaver K, Smith V, Lewis JD, et al: ACT-based computerized treatment planning system for 1-125 stereotactic brain implants. Int J Radiât Oncol Biol Phys 1990; 18:445-454.
5. Schulz RJ, Chandra P, Nath R: Determination of the exposure rate constant for I23I using a scintillation detector. Med Phys 1980; 7:355-361.
6. Bernstein M, Gutin PH: Interstitial irradiation of brain tumors: a review. Neurosurgery 1981; 9:741-750.
7. Hall EJ: The biological basis of endocurietherapy. Endocur Hypertherm Oncol 1985; 1:141-152.
8. Hall EJ: The promise of low dose rate: has it been realized? Int J Radiât Oncol Biol Phys 1978; 4:749-750.
9. Hall EJ: Radiation dose-rate: a factor of importance in radiobiology and radiotherapy [Review]. Br J Radiol 1972; 45:81-97.
10. Schultz CJ, Geard CR: Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiât Oncol Biol Phys 1990; 19:1397-1403.
11. Knox SJ, Sutherland W, Goris ML: Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase bloc and other radiobiological parameters published erratum appears in Radiât Res 1993; 136:439]. Radial Res 1993; 135:24-31.
12. Arbit E, Shapiro JR, Fiola M, et al: The significance of morphologically viable glioma cells found at the time of operation after interstitial brachytherapy. Neurosurgery 1993; 32:105-110.
13. Gutin PH, Bernstein M, Sano Y, Deen DF: Combination therapy with l,3-bis(2-chloroethyl)-l-nilrosourea and low dose rate radiation in the 9L rat brain tumor and sphenoid models: implications for brain tumor brachytherapy. Neurosurgery 1984; 15:781-786.
14. Cosgrove GR, Hochberg FH, Zervas NT, et al: Interstitial irradiation of brain tumors using a miniature radiosurgery device: initial experience. Neurosurgery 1997; 40:518-523.
15. Dewey WC, Freeman ML, Raaphorst GP, et al.: Cell biology of hyperthermia and radiation. In Meyn RE, Withers HR (eds): "Radiation biology in cancer research". New York: Raven Press; 1980. p. 589-621.
16. Hoopes PJ, Ryan TP, DeLeo JA, et al.: Thermotolerant effects of corticosteroids or preheating on hyperthermia induced lesions in dog brain. Tenth annual meeting of the North American Hyperthermia Group, New Orleans, Louisiana; 1990: 7.
17. Overgaard J: The current and potential role for hyperthermia in radiotherapy [Review]. Int J Radiât Oncol Biol Phys 1989; 16:535-549.
18. Sneed PK, Gutin PH, Stauffer PR, et al: Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiât Oncol Biol Phys 1992; 23:853-861.
19. Florell RC, Macdonald DR, Irish WD, et al: Selection bias, survival, and brachytherapy for glioma [published erratum appears in J Neurosurg 1992; 77:489]. J Neurosurg 1992; 76:179-183.
20. Selker RG, Shapiro WR, Green S, et al: A randomized trial of interstitial radiotherapy (1RT) boost for the treatment of newly diagnosed malignant glioma (glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, malignant mixed glioma): BTCG study 87-01 [abstract]. Congress of Neurological Surgeons 45th Annual Meeting Program; 1995 Oct 14-19; San Francisco; 1995; 94-95.
21. Lucas GL, Luxton G, Cohen D, et al: Treatment results of stereotactic interstitial brachytherapy for primary and metastatic brain tumors. Int J Radial Oncol Biol Phys 1991; 21:715-721.
22. Zamorano L, Yakar D, Dujovny M, et al: Permanent iodine125 implant and external beam radiation therapy for the ireatment of malignant brain lumors. Stereotact Funcl Neurosurg 1992; 59:183-192.
23. Malkin MG: Inlerstilial brachytherapy of malignanl gliomas: the Memorial Sloan- Kettering Cancer Cenler experience. Recenl Resulls Cancer Res 1994; 135:117-125.
24. Wen PY, Alexander EA 3rd, Black PM, el al: Long lerm resulls of stereotaclic brachylherapy used in ihe inilial treatmenl of palienls with glioblastomas. Cancer 1994; 73:3029-3036.
25. Sneed PK, Prados MD, McDermott MW, et al: Large effect of age on the survival of palienls wilh glioblasloma Ireated wilh radioIherapy and brachylherapy boost. Neurosurgery 1995; 36:898-904.
26. Gutin PH, Prados MD, Phillips TL, el al: Exlernal irradiation followed by an interstitial high activily iodine-125 implant "boost" in Ihe inilial Irealment of malignant gliomas: NCOG Study 6G-82-2. Int J Radial Oncol Biol Phys 1991; 21:601-606.
27. Levin VA, Silver P, Hannigan J, el al: Superiorily of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 Final Report. Int J Radial Oncol Biol Phys 1990; 18:321-324.
28. Prados MD, Gutin PH, Phillips TL, et al: Interstilial brachylherapy for newly diagnosed patients with malignant gliomas: ihe UCSF experience. Inl J Radial Oncol Biol Phys 1992; 24:593-597.
29. Sneed PK, Stauffer MS, Diederich CJ, et al: Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ±hyperthermia for glioblastoma multiforme [abslracl]. Inl J Radial Oncol Biol Phys 1996; 36(Suppl 1):159.
30. Stea B, Rossman K, Kittclson J, et al.: Interstitial irradiation vs. interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis. Int J Radiât Oncql Biol Phys 1994; 30:591-600.
31. Sneed PK, Gutin PH, Larson DA, et al: Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiât Oncol Biol Phys 1994; 29: 719-727.
32. Agbi CB, Bernstein M, Laperriere N, et al: Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants. Int J Radiât Oncol Biol Phys 1992; 23:321-326.
33. Loeffler JS, Alexander E 3rd, Hochberg FH, et al: Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiât Oncol Biol Phys 1990; 19:1455-1462.
34. Schupak K, Malkin M, Anderson L, et al: The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence. Int J Radiât Oncol Biol Phys 1995; 32: 1167-1176.
35. Etou A, Mundinger F, Mohadjer M, Birg W: Stereotactic interstitial irradiation of diencephalic tumors with indium 192 and iodine 125: 10 years follow-up and comparison with other treatments [Review]. Childs Nerv Syst 1989; 5:140-143.
36. Larson GL, Wilbanks JH, Dennis WS, et al: Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas. Cancer 1990; 66:27-29.
37. Mundinger F: Stereotactic Curie-therapy of pituitary adenomas. A long-term follow-up study. Acta Neurochir Suppl 1974; 21:169-176.
38. Mundinger F, Braus DF, Krauss JK, Birg W: Long-term outcome of 89 low-grade brain-stem gliomas after interstitial radiation therapy. J Neurosurg 1991; 75:740-746.
39. Mundinger F, Hoefer T: Protracted long-term irradiation of inoperable midbrain tumours by stereotactic Curie-therapy using iridium192. Acta Neurochir Suppl 1974; 21:93-100.
40. Mundinger F, Ostertag C: Post-operative stereotactic Curie-therapy using the iridium-192 GammaMed contact irradiation apparatus combined with radio-sensitizers in treating multiform glioblastomas. Acta Neurochir 1978; 42:73-77.
41. Mundinger F, Weigel K: Indication and results of stereotactic Curietherapy with iridium-192 and iodine-125 for non-resectable tumors of the hypothalamic region. Acta Neurochir Suppl 1984; 33:323-330.
42. Ostertag CB, Kreth FW: Iodine-125 interstitial irradiation for cerebral gliomas. Acta Neurochir 1992; 119:53-61.
43. Zamorano L, Vinas FC, Caspar L, et al: I-125 permanent implants in the up-front management of primary glioblastoma multiforme Poster 094 [abstract]. In International Stereotactic Radiosurgery Society annual meeting program; 1997 June 25-28; Madrid, Spain; 1997; 198.
44. Zamorano L, Vinas FC, Caspar L, et al: I-125 permanent implants in the up-front management of primary anaplastic astrocytomas Poster 095 [abstract]. In International Stereotactic Radiosurgery Society annual meeting program; 1997 June 25-28; Madrid, Spain; 1997; 199.
45. Kreth FW, Faist M, Warnke PC, et al.: Interstitial radiosurgery of low-grade gliomas. J Neurosurg 1995; 82:418-429.
46. Gutin PH, Leibel SA, Wara WM, et al.: Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources [published erratum appears in J Neurosurg 1988; 68:990][Review]. J Neurosurg 1987; 67:864-873.
47. Scharfen CO, Sneed PK, Wara WM, et al: High activity iodine-125 interstitial implant for gliomas. Int J Radiât Oncol Biol Phys 1992; 24:583-591.
48. Kitchen ND, Hughes SW, Taub NA, et al: Survival following interstitial brachytherapy for recurrent malignant glioma. J Neurooncol 1994; 18:33-39.
49. Ryken TC, Hitchon PW, VanGilder JC, et al: Interstitial brachytherapy versus cytoreductive surgery in recurrent malignant glioma. Stereotact Funct Neurosurg 1994; 63:241-245.
50. Bernstein M, Laperriere N, Glen J, et al: Brachytherapy for recurrent malignant astrocytoma. Int J Radiât Oncol Biol Phys 1994; 30:1213-1217.
51. Chamberlain MC, Barba D, Kormanik P, et al: Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors. Arch Neurol 1995; 52:162-167.
52. Shrieve DC, Alexander E 3rd, Wen PY, et al: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 1995; 36: 275-284.
53. McDermott MW, Cosgrove GR, Larson DA, et al: Interstitial brachytherapy for intracranial métastases. Neurosurg Clin North Am 1996; 7:485195.
54. Prados M, Leibel S, Barnett CM, Gutin P: Interstitial brachytherapy for metastatic brain tumors. Cancer 1989; 63:657-660.
55. Bernstein M, Cabantog A, Laperriere N, et al: Brachytherapy for recurrent single brain métastases. Can J Neurol Sei 1995; 22:13-16.
56. Healey EA, Shamberger RC, Grier HE, et al: A 10-year experi-ence of pédiatrie brachytherapy. Int J Radiât Oncol Biol Phys 1995; 32:451-455.
57. Sneed PK, Russo C, Scharfen CO, et al.: Long-term follow-up after high-activity 1251 brachytherapy for pédiatrie brain tumors. Pediatr Neurosurg 1996; 24:314-322.
58. Saenz A, Zamarano L, Buciuc R, et al: Permanent 1-125 implants in the treatment of pédiatrie brain tumors - Poster 093 [abstract]. In International Stereotactic Radiosurgery Society annual meeting program; 1997 June 25-28; Madrid, Spain; 1997; 197.
59. Leibel SA, Gutin PH, Wara WM, et al: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. IntJ Radiât Oncol Biol Phys 1989; 17:1129-1139.